209 related articles for article (PubMed ID: 12952030)
1. The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease.
Peh SC; Shaminie J; Poppema S; Kim LH
Singapore Med J; 2003 Apr; 44(4):185-91. PubMed ID: 12952030
[TBL] [Abstract][Full Text] [Related]
2. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid variant of hyaline vascular Castleman's disease containing numerous mantle zone lymphocytes with clear cytoplasm.
Kojima M; Nakamura S; Iijima M; Murayama K; Sakata N; Masawa N
APMIS; 2005 Jan; 113(1):75-80. PubMed ID: 15676019
[TBL] [Abstract][Full Text] [Related]
4. Castleman's disease with numerous mantle zone lymphocytes with clear cytoplasm involving the skin: case report.
Tomasini D; Zampatti C; Serio G
J Cutan Pathol; 2009 Aug; 36(8):887-91. PubMed ID: 19586499
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases.
Zarate-Osorno A; Medeiros LJ; Danon AD; Neiman RS
Arch Pathol Lab Med; 1994 Mar; 118(3):270-4. PubMed ID: 8135630
[TBL] [Abstract][Full Text] [Related]
6. Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies.
Chilosi M; Menestrina F; Lestani M; Bonetti F; Scarpa A; Caligaris-Cappio F; Pizzolo G; Perini A; Fiore-Donati L
Histol Histopathol; 1987 Jan; 2(1):49-55. PubMed ID: 2980702
[TBL] [Abstract][Full Text] [Related]
7. Castleman's disease of the leptomeninges--immunohistochemical findings in 2 cases.
Ropponen KM; Kankkunen JP; Ronkainen A; Vihavainen M; Alafuzoff I
Clin Neuropathol; 2002; 21(6):278-83. PubMed ID: 12489677
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD5+ marginal zone B-cell lymphoma resembling the plasma cell variant of Castleman's disease. Case report.
Tsukamoto N; Kojima M; Uchiyama T; Takeuchi T; Karasawa M; Murakami H; Sato S
APMIS; 2007 Dec; 115(12):1426-31. PubMed ID: 18184415
[TBL] [Abstract][Full Text] [Related]
9. Progressive transformation of germinal center presenting with histological features of hyaline-vascular type of Castleman's disease.
Kojima M; Nakamura S; Miyawaki S; Ohno Y; Sakata N; Masawa N
APMIS; 2005 Apr; 113(4):288-95. PubMed ID: 15865611
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous B cell processes with nodular pattern].
Chirife AM; Bilbao ER; Giménez L; Marino L
Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
[TBL] [Abstract][Full Text] [Related]
13. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
Vasudev Rao T; Alkindi S; Pathare AV
Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases.
Kojima M; Nakamura S; Nishikawa M; Itoh H; Miyawaki S; Masawa N
Pathol Res Pract; 2005; 201(4):325-32. PubMed ID: 15991840
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
[TBL] [Abstract][Full Text] [Related]
16. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
[TBL] [Abstract][Full Text] [Related]
17. Cytomorphology of hyaline-vascular Castleman's disease: a diagnostic challenge.
Mallik MK; Kapila K; Das DK; Haji BE; Anim JT
Cytopathology; 2007 Jun; 18(3):168-74. PubMed ID: 17488256
[TBL] [Abstract][Full Text] [Related]
18. Angiofollicular lymph node hyperplasia (Castleman's disease): an immunohistochemical and enzyme-histochemical study of the hyaline-vascular form of lesion.
Jones EL; Crocker J; Gregory J; Guibarra M; Curran RC
J Pathol; 1984 Oct; 144(2):131-47. PubMed ID: 6092594
[TBL] [Abstract][Full Text] [Related]
19. Castleman's disease.
Palestro G; Turrini F; Pagano M; Chiusa L
Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
[TBL] [Abstract][Full Text] [Related]
20. Multicentric Castleman's disease in a child with prominent thymic involvement: a case report and brief review of the literature.
O'Reilly PE; Joshi VV; Holbrook CT; Weisenburger DD
Mod Pathol; 1993 Nov; 6(6):776-80. PubMed ID: 8302822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
